1. Home
  2. CLNE vs ALT Comparison

CLNE vs ALT Comparison

Compare CLNE & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clean Energy Fuels Corp.

CLNE

Clean Energy Fuels Corp.

HOLD

Current Price

$2.04

Market Cap

500.3M

Sector

Utilities

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.90

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLNE
ALT
Founded
2001
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
500.3M
421.5M
IPO Year
2006
2005

Fundamental Metrics

Financial Performance
Metric
CLNE
ALT
Price
$2.04
$2.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$3.32
$17.67
AVG Volume (30 Days)
1.3M
2.7M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.37
EPS
N/A
N/A
Revenue
$341,599,000.00
$41,000.00
Revenue This Year
$1.13
N/A
Revenue Next Year
$22.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
105.00
52 Week Low
$1.73
$2.56
52 Week High
$3.11
$7.73

Technical Indicators

Market Signals
Indicator
CLNE
ALT
Relative Strength Index (RSI) 42.57 44.10
Support Level N/A $2.87
Resistance Level $2.40 $4.19
Average True Range (ATR) 0.07 0.12
MACD 0.01 0.02
Stochastic Oscillator 41.24 41.46

Price Performance

Historical Comparison
CLNE
ALT

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas and liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The firm operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. It also builds, operates, and maintains natural gas fueling stations for customers.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: